PMV PHARMACEUTICALS, INC. Workers' Compensation Liability, Current
PMV PHARMACEUTICALS, INC. (PMVP) had Workers' Compensation Liability, Current of $3.20 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Accrued Liabilities, Current
us-gaap:WorkersCompensationLiabilityCurrent · last filed 2026-08-14
- 2026-06-30: Workers' Compensation Liability, Current $3.20M.
- 2026-03-31: Workers' Compensation Liability, Current $2.42M.
- 2025-12-31: Workers' Compensation Liability, Current $4.53M.
- 2025-09-30: Workers' Compensation Liability, Current $3.92M.
| Period end | Workers' Compensation Liability, Current | Workers' Compensation Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $3.20M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.42M 10-Q · filed 2026-05-12 | |
| 2025-12-31 | $4.53M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $3.92M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $3.06M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $2.78M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $5.00M 10-K · filed 2026-03-06 | |
| 2024-09-30 | $4.00M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $3.00M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.22M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $4.50M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $3.77M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.72M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $1.85M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $2.90M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $2.96M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $2.51M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $1.76M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $3.80M 10-K · filed 2023-03-01 | |
| 2021-09-30 | $2.88M 10-Q · filed 2021-11-12 | |
| 2021-06-30 | $2.16M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | $1.81M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $3.11M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $2.10M 10-Q · filed 2020-11-13 | |
| 2019-12-31 | $1.65M 10-K · filed 2021-03-03 | $1.65M 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |